Non–HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - Jama, 2005 - jamanetwork.com
ContextCurrent guidelines for cardiovascular risk detection are controversial with regard to
the clinical utility of different lipid measures, non–high-density lipoprotein cholesterol (non …

Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - 2005 - cabidigitallibrary.org
Context: Current guidelines for cardiovascular risk detection are controversial with regard to
the clinical utility of different lipid measures, non-high-density lipoprotein cholesterol (non …

[引用][C] Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

PM RIDKER, N RIFAI, NR COOK… - JAMA, the journal of …, 2005 - pascal-francis.inist.fr
Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and
CRP as risk factors for cardiovascular disease in women CNRS Inist Pascal-Francis CNRS …

[引用][C] Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - JAMA, 2005 - cir.nii.ac.jp
Non–HDL Cholesterol, Apolipoproteins AI and B<sub>100</sub>, Standard Lipid Measures,
Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women | CiNii Research …

Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women.

PM Ridker, N Rifai, NR Cook… - JAMA: Journal of the …, 2005 - search.ebscohost.com
Context Current guidelines for cardiovascular risk detection are controversial with regard to
the clinical utility of different lipid measures, non–high-density lipoprotein cholesterol (non …

[PDF][PDF] Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - JAMA, 2005 - researchgate.net
Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein
cholesterol (LDL-C), HDL-C, non–HDL-C, apolipoproteins AI and B100, highsensitivity CRP …

[引用][C] Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

PM Ridker, N Rifai, NR Cook, G Bradwin… - ACC Current Journal …, 2005 - infona.pl
Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios,
and CRP as Risk Factors for Cardiovascular Disease in Women × Close The Infona portal …

Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - JAMA, 2005 - europepmc.org
Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein
cholesterol (LDL-C), HDL-C, non-HDL-C, apolipoproteins AI and B (100), high-sensitivity …

[PDF][PDF] Non–HDL Cholesterol, Apolipoproteins AI and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - JAMA, 2005 - academia.edu
Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein
cholesterol (LDL-C), HDL-C, non–HDL-C, apolipoproteins AI and B100, highsensitivity CRP …

Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

PM Ridker, N Rifai, NR Cook, G Bradwin… - JAMA, 2005 - pubmed.ncbi.nlm.nih.gov
Context Current guidelines for cardiovascular risk detection are controversial with regard to
the clinical utility of different lipid measures, non-high-density lipoprotein cholesterol (non …